A recent study by Hlavac et al. (2021) pointed out the association of a specific variant, rs17102977, in the CYP4X1 gene with the response of breast cancer patients to neoadjuvant cytotoxic chemotherapy. This evidence concerns the gene CYP4X1 and breast cancer.